It acts as a GLP-1 receptor agonist, reducing blood sugar by increasing insulin release and reducing glucagon
Unlike traditional GLP-1-only medications such as Semaglutide (generic Ozempic, Wegovy), Tirzepatide is a dual-action therapy that targets both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
Collagen l thn dc hiu qu cao cho ln da cng trn, sng mn y sc sng
they're unregulated, potentially impure, and lack dosage precision, posing health risks like bacterial contamination or heavy metals.[44][45][46] Unregulated online sources amplify dangers with potential counterfeits, unknown additives, or legal violations, as they're not FDA-approved and may lead to adverse effects or inefficacy.[47][48][49] Prioritize compounding pharmacies for reliable, compliant options
In two randomized trials with a total of 500 patients, researchers studied the effects of tirzepatide (titrated to 10 mg or 15mg weekly) versus placebo in people with obesity (average body-mass index [BMI], 39 kg/m 2 ) and moderate-to-severe